Atrial fibrillation: the cost of illness in Sweden

go back to reference Fuster, V., Rydén, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S., Smith Jr, S.C., Jacobs, A.K., Adams, C.D., Anderson, J.L., Antman, E.M., Hunt, S.A., Nishimura, R., Ornato, J.P., Page, R.L., Riegel, B., Priori, S.G., Blanc, J.J., Budaj, A., Camm, A.J., Dean, V., Deckers, J.W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Zamorano, J.L.: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8, 651–745 (2006)PubMedCrossRef Fuster, V., Rydén, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S., Smith Jr, S.C., Jacobs, A.K., Adams, C.D., Anderson, J.L., Antman, E.M., Hunt, S.A., Nishimura, R., Ornato, J.P., Page, R.L., Riegel, B., Priori, S.G., Blanc, J.J., Budaj, A., Camm, A.J., Dean, V., Deckers, J.W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Zamorano, J.L.: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8, 651–745 (2006)PubMedCrossRef

go back to reference Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., Singer, D.E.: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285, 2370–2375 (2001)PubMedCrossRef Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., Singer, D.E.: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285, 2370–2375 (2001)PubMedCrossRef

go back to reference Butler, R.N.: Population aging and health. BMJ 315, 1082–1084 (1997)PubMed Butler, R.N.: Population aging and health. BMJ 315, 1082–1084 (1997)PubMed

go back to reference MacIntyre, K., Capewell, S., Stewart, S., Chalmers, J.W., Boyd, J., Finlayson, A., Redpath, A., Pell, J.P., McMurray, J.J.: Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 102, 1126–1131 (2000)PubMed MacIntyre, K., Capewell, S., Stewart, S., Chalmers, J.W., Boyd, J., Finlayson, A., Redpath, A., Pell, J.P., McMurray, J.J.: Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 102, 1126–1131 (2000)PubMed

go back to reference Peltonen, M., Stegmayr, B., Asplund, K.: Time trends in long-term survival after stroke: the Northern Sweden Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study, 1985–1994. Stroke 29, 1358–1365 (1998)PubMedCrossRef Peltonen, M., Stegmayr, B., Asplund, K.: Time trends in long-term survival after stroke: the Northern Sweden Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study, 1985–1994. Stroke 29, 1358–1365 (1998)PubMedCrossRef

go back to reference Rosamond, W.D., Chambless, L.E., Folsom, A.R., Cooper, L.S., Conwill, D.E., Clegg, L., Wang, C.H., Heiss, G.: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 339, 861–867 (1998)PubMedCrossRef Rosamond, W.D., Chambless, L.E., Folsom, A.R., Cooper, L.S., Conwill, D.E., Clegg, L., Wang, C.H., Heiss, G.: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 339, 861–867 (1998)PubMedCrossRef

go back to reference Schaufelberger, M., Swedberg, K., Köster, M., Rosén, M., Rosengren, A.: Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur. Heart J. 25, 300–307 (2004)PubMedCrossRef Schaufelberger, M., Swedberg, K., Köster, M., Rosén, M., Rosengren, A.: Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur. Heart J. 25, 300–307 (2004)PubMedCrossRef

go back to reference Stegmayr, B., Asplund, K.: Stroke in Northern Sweden. Scand. J. Public Health Suppl. 61, 60–69 (2003)PubMedCrossRef Stegmayr, B., Asplund, K.: Stroke in Northern Sweden. Scand. J. Public Health Suppl. 61, 60–69 (2003)PubMedCrossRef

go back to reference Le Heuzey, J.Y., Paziaud, O., Piot, O., Said, M.A., Copie, X., Lavergne, T., Guize, L.: Cost of care distribution in atrial fibrillation patients: the COCAF study. Am. Heart J. 147, 121–126 (2004)PubMedCrossRef Le Heuzey, J.Y., Paziaud, O., Piot, O., Said, M.A., Copie, X., Lavergne, T., Guize, L.: Cost of care distribution in atrial fibrillation patients: the COCAF study. Am. Heart J. 147, 121–126 (2004)PubMedCrossRef

go back to reference McBride, D., Mattenklotz, A.M., Willich, S.N., Brüggenjürgen, B.: The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health 12, 293–301 (2008)PubMedCrossRef McBride, D., Mattenklotz, A.M., Willich, S.N., Brüggenjürgen, B.: The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health 12, 293–301 (2008)PubMedCrossRef

go back to reference Reynolds, M.R., Essebag, V., Zimetbaum, P., Cohen, D.J.: Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J. Cardiovasc. Electrophysiol. 18, 628–633 (2007)PubMedCrossRef Reynolds, M.R., Essebag, V., Zimetbaum, P., Cohen, D.J.: Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J. Cardiovasc. Electrophysiol. 18, 628–633 (2007)PubMedCrossRef

go back to reference Ringborg, A., Nieuwlaat, R., Lindgren, P., Jönsson, B., Fidan, D., Maggioni, A.P., Lopez-Sendon, J., Stepinska, J., Cokkinos, D.V., Crijns, H.J.: Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10, 403–411 (2008)PubMedCrossRef Ringborg, A., Nieuwlaat, R., Lindgren, P., Jönsson, B., Fidan, D., Maggioni, A.P., Lopez-Sendon, J., Stepinska, J., Cokkinos, D.V., Crijns, H.J.: Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10, 403–411 (2008)PubMedCrossRef

go back to reference Stewart, S., Murphy, N.F., Walker, A., McGuire, A., McMurray, J.J.: Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 90, 286–292 (2004)PubMedCrossRef Stewart, S., Murphy, N.F., Walker, A., McGuire, A., McMurray, J.J.: Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 90, 286–292 (2004)PubMedCrossRef

go back to reference Ekman, M.: Economic evidence in stroke: a review. Eur. J. Health Econ. 5, S74–S83 (2004)PubMedCrossRef Ekman, M.: Economic evidence in stroke: a review. Eur. J. Health Econ. 5, S74–S83 (2004)PubMedCrossRef

go back to reference Henriksson, F., Jönsson, B.: Diabetes: the cost of illness in Sweden. J. Intern. Med. 244, 461–468 (1998)PubMedCrossRef Henriksson, F., Jönsson, B.: Diabetes: the cost of illness in Sweden. J. Intern. Med. 244, 461–468 (1998)PubMedCrossRef

go back to reference Nieuwlaat, R., Capucci, A., Camm, A.J., Olsson, S.B., Andresen, D., Davies, D.W., Cobbe, S., Breithardt, G., Le Heuzey, J.Y., Prins, M.H., Lévy, S., Crijns, H.J.: Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 26, 2422–2434 (2005)PubMedCrossRef Nieuwlaat, R., Capucci, A., Camm, A.J., Olsson, S.B., Andresen, D., Davies, D.W., Cobbe, S., Breithardt, G., Le Heuzey, J.Y., Prins, M.H., Lévy, S., Crijns, H.J.: Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 26, 2422–2434 (2005)PubMedCrossRef

go back to reference Auricula. The atrial fibrillation and anticoagulation registry. Annual report 2007 (In Swedish) (2007). Available at: http://www.ucr.uu.se/auricula. Accessed March 2009 Auricula. The atrial fibrillation and anticoagulation registry. Annual report 2007 (In Swedish) (2007). Available at: http://​www.​ucr.​uu.​se/​auricula. Accessed March 2009

go back to reference Davidson, T., Levin, L.Å.: Kostnaden för förmaksflimmer i Östergötland. CMT Report 2006:5 (In Swedish) (2006). Available at: http://www.ep.liu.se/ea/cmt/2006/005/. Accessed March 2009 Davidson, T., Levin, L.Å.: Kostnaden för förmaksflimmer i Östergötland. CMT Report 2006:5 (In Swedish) (2006). Available at: http://​www.​ep.​liu.​se/​ea/​cmt/​2006/​005/​. Accessed March 2009

go back to reference Friberg, L., Hammar, N., Rosenqvist, M.: Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur. Heart J. 31, 967–975 (2010)PubMedCrossRef Friberg, L., Hammar, N., Rosenqvist, M.: Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur. Heart J. 31, 967–975 (2010)PubMedCrossRef

go back to reference Nilsson, G.H., Björholt, I.: Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records. BMC Clin. Pharmacol. 4, 1 (2004)PubMedCrossRef Nilsson, G.H., Björholt, I.: Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records. BMC Clin. Pharmacol. 4, 1 (2004)PubMedCrossRef

go back to reference FASS, Pharmaceutical Specialties in Sweden (2009). Available at: http://www.fass.se. Accessed March 2009 FASS, Pharmaceutical Specialties in Sweden (2009). Available at: http://​www.​fass.​se. Accessed March 2009

go back to reference Björholt, I., Andersson, S., Nilsson, G.H., Krakau, I.: The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden. BMC Fam. Pract. 8, 6 (2007)PubMedCrossRef Björholt, I., Andersson, S., Nilsson, G.H., Krakau, I.: The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden. BMC Fam. Pract. 8, 6 (2007)PubMedCrossRef

go back to reference Björholt, I., Andersson, F.L., Kahan, T., Östergren, J.: The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study. J. Intern. Med. 251, 508–517 (2002)PubMedCrossRef Björholt, I., Andersson, F.L., Kahan, T., Östergren, J.: The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study. J. Intern. Med. 251, 508–517 (2002)PubMedCrossRef

go back to reference Atrial fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154, 1449–1457 (1994)CrossRef Atrial fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154, 1449–1457 (1994)CrossRef

go back to reference The Swedish National Board of Health and Welfare. [National guidelines]. Nationella riktlinjer för strokesjukvård. Beslutsstöd för prioriteringar (In Swedish) (2009). Available at: http://www.socialstyrelsen.se. Accessed March 2009 The Swedish National Board of Health and Welfare. [National guidelines]. Nationella riktlinjer för strokesjukvård. Beslutsstöd för prioriteringar (In Swedish) (2009). Available at: http://​www.​socialstyrelsen.​se. Accessed March 2009

go back to reference Ghatnekar, O., Persson, U., Glader, E.L., Terent, A.: Cost of stroke in Sweden: an incidence estimate. Int. J. Technol. Assess. Health Care 20, 375–380 (2004)PubMedCrossRef Ghatnekar, O., Persson, U., Glader, E.L., Terent, A.: Cost of stroke in Sweden: an incidence estimate. Int. J. Technol. Assess. Health Care 20, 375–380 (2004)PubMedCrossRef

go back to reference Ghatnekar, O., Glader, E.L.: The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Value Health 11, 862–868 (2008)PubMedCrossRef Ghatnekar, O., Glader, E.L.: The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Value Health 11, 862–868 (2008)PubMedCrossRef

go back to reference Agvall, B., Dahlström, U.: Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences. Scand. J. Prim. Health Care 19, 14–19 (2001)PubMedCrossRef Agvall, B., Dahlström, U.: Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences. Scand. J. Prim. Health Care 19, 14–19 (2001)PubMedCrossRef

go back to reference Mejhert, M., Persson, H., Edner, M., Kahan, T.: Epidemiology of heart failure in Sweden—a national survey. Eur. J. Heart Failure 3, 97–103 (2001)CrossRef Mejhert, M., Persson, H., Edner, M., Kahan, T.: Epidemiology of heart failure in Sweden—a national survey. Eur. J. Heart Failure 3, 97–103 (2001)CrossRef

go back to reference Medical Products Agency: Diagnostik och behandling av kronisk hjärtsvikt—behandlingsrekommendationer (In Swedish). Information från Läkemedelsverket 17, 7–17 (2006) Medical Products Agency: Diagnostik och behandling av kronisk hjärtsvikt—behandlingsrekommendationer (In Swedish). Information från Läkemedelsverket 17, 7–17 (2006)

go back to reference Miyasaka, Y., Barnes, M.E., Gersh, B.J., Cha, S.S., Bailey, K.R., Abhayaratna, W., Seward, J.B., Iwasaka, T., Tsang, T.S.: Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur. Heart J. 27, 936–941 (2006)PubMedCrossRef Miyasaka, Y., Barnes, M.E., Gersh, B.J., Cha, S.S., Bailey, K.R., Abhayaratna, W., Seward, J.B., Iwasaka, T., Tsang, T.S.: Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur. Heart J. 27, 936–941 (2006)PubMedCrossRef

go back to reference Wang, T.J., Larson, M.G., Levy, D., Vasan, R.S., Leip, E.P., Wolf, P.A., D’Agostino, R.B., Murabito, J.M., Kannel, W.B., Benjamin, E.J.: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107, 2920–2925 (2003)PubMedCrossRef Wang, T.J., Larson, M.G., Levy, D., Vasan, R.S., Leip, E.P., Wolf, P.A., D’Agostino, R.B., Murabito, J.M., Kannel, W.B., Benjamin, E.J.: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107, 2920–2925 (2003)PubMedCrossRef

go back to reference Agvall, B., Borgquist, L., Foldevi, M., Dahlström, U.: Cost of heart failure in Swedish primary healthcare. Scand. J. Prim. Health Care 23, 227–232 (2005)PubMedCrossRef Agvall, B., Borgquist, L., Foldevi, M., Dahlström, U.: Cost of heart failure in Swedish primary healthcare. Scand. J. Prim. Health Care 23, 227–232 (2005)PubMedCrossRef

go back to reference Rho, R.W., Page, R.L.: Asymptomatic atrial fibrillation. Prog. Cardiovasc. Dis. 48, 79–87 (2005)PubMedCrossRef Rho, R.W., Page, R.L.: Asymptomatic atrial fibrillation. Prog. Cardiovasc. Dis. 48, 79–87 (2005)PubMedCrossRef

go back to reference Moeremans, K., Aliot, E., de Chillou, C., Annemans, L., Le Pen, C., de Jong, P.: Second line pharmacological management of paroxysmal and persistent atrial fibrillation in France: a cost analysis. Value Health 3, 407–416 (2000)PubMedCrossRef Moeremans, K., Aliot, E., de Chillou, C., Annemans, L., Le Pen, C., de Jong, P.: Second line pharmacological management of paroxysmal and persistent atrial fibrillation in France: a cost analysis. Value Health 3, 407–416 (2000)PubMedCrossRef

go back to reference Sobocki, P., Lekander, I., Borgström, F., Ström, O., Runeson, B.: The economic burden of depression in Sweden from 1997 to 2005. Eur. Psychiatry 22, 146–152 (2007)PubMedCrossRef Sobocki, P., Lekander, I., Borgström, F., Ström, O., Runeson, B.: The economic burden of depression in Sweden from 1997 to 2005. Eur. Psychiatry 22, 146–152 (2007)PubMedCrossRef

go back to reference Lidgren, M., Wilking, N., Jönsson, B.: Cost of breast cancer in Sweden in 2002. Eur. J. Health Econ. 8, 5–15 (2007)PubMedCrossRef Lidgren, M., Wilking, N., Jönsson, B.: Cost of breast cancer in Sweden in 2002. Eur. J. Health Econ. 8, 5–15 (2007)PubMedCrossRef

go back to reference Borgström, F., Sobocki, P., Ström, O., Jönsson, B.: The societal burden of osteoporosis in Sweden. Bone 40, 1602–1609 (2007)PubMedCrossRef Borgström, F., Sobocki, P., Ström, O., Jönsson, B.: The societal burden of osteoporosis in Sweden. Bone 40, 1602–1609 (2007)PubMedCrossRef